 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on May 29, 2024 |
| Title |
Maintenance of ESLAM haematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Adult haematopoietic stem cells (HSCs) are responsible for the lifelong production of blood and immune cells and must respond to extracellular cues including cytokines. The JAK/STAT pathway is a highly conserved pathway, activated by many cytokines, in which tyrosine-phosphorylated STATs (pSTATs) function as transcription factors. STAT5 is a pivotal downstream mediator of several cytokines known to regulate haematopoiesis but its function in the HSC compartment remains poorly understood. Here we show that STAT5-deficient HSCs exhibited an unusual phenotype - reduced multi-lineage repopulation and self-renewal combined with reduced cell cycle entry and increased differentiation. This reflected not only loss of a canonical pSTAT5 transcriptional program but also loss of distinct functions mediated by tyrosine-unphosphorylated STAT5 (uSTAT5). Consistent with this concept expression of an unphosphorylatable STAT5B mutant constrained HSC differentiation, promoted HSC maintenance and upregulated transcriptional programs associated with quiescence and stemness. Moreover, treatment with a JAK1/2 inhibitor (ruxolitinib) increased the uSTAT5:pSTAT5 ratio, constrained HSC differentiation and proliferation and promoted HSC maintenance, thus phenocopying uSTAT5B overexpression. Our results therefore reveal a previously unrecognized interplay between pSTAT5 and uSTAT5 in the control of HSC function. In addition the demonstration that JAK inhibition promotes HSC maintenance has implications for gene therapy using HSCs and may contribute to the failure of JAK inhibitors to eradicate myeloproliferative neoplasms.
|
| |
|
| Overall design |
Bone Marrow resident ESLAM HSCs were sorted from WT and STAT5-deficient mice and submitted for plate based single cell RNA sequencing by Smartseq2
|
| |
|
| Contributor(s) |
Williams MJ, Li J, Bastos HP, Wang X, Wantoch M, Park HJ, Grondys-Kotarba G, Pask DC, Hamilton TL, Wilson NK, Asby R, Sneade R, Kinston SJ, Laurenti E, Vassiliou GS, Göttgens B, Green AR |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Jan 20, 2023 |
| Last update date |
May 29, 2024 |
| Contact name |
Hugo P. Bastos |
| E-mail(s) |
hpb29@cam.ac.uk
|
| Organization name |
Wellcome - MRC Cambridge Stem Cell Institute
|
| Department |
Haematology
|
| Street address |
Jeffrey Cheah Biomedical Centre, Puddicombe Way
|
| City |
Cambridge |
| ZIP/Postal code |
CB2 0AW |
| Country |
United Kingdom |
| |
|
| Platforms (1) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
| Samples (288)
|
|
| Relations |
| BioProject |
PRJNA925879 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE223366_SLX14260_ESLAM_filtered_cells_and_genes_transformed_data.h5ad.gz |
59.5 Mb |
(ftp)(http) |
H5AD |
| GSE223366_SLX14260_HTSeq_counts.txt.gz |
4.1 Mb |
(ftp)(http) |
TXT |
SRA Run Selector |
| Raw data are available in SRA |
| Processed data are available on Series record |
|
|
|
|
 |
Less...
More...